NMS Capital Portfolio Company Flourish Research Announces Partnerships with Great Lakes Clinical Trials and Clinical Site Partners, Creating One of the Largest Clinical Site Networks in the United States
New York, NY, January 12, 2022 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish” or the “Company”) announced today that it has partnered with company management in the recapitalizations of Great Lakes Clinical Trials (“Great Lakes”) and Clinical Site Partners (“CSP”), which are both leading clinical research sites. The transactions mark the third and […]